Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer

European Journal of Cancer

Volumn 45, Issue 5, 2009, Pages 795-799

  Dixon, J M ^a   Mak, C ^a   Radhakrishna, S ^a   Kehoe, T ^a   Millar, A M ^b   Wong, D ^a   Thomas, J St J ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Breast cancer; Sentinel node biopsy (SNB)

Indexed keywords

BLUE DYE; DISULFINE BLUE; DYE; NANOCOLL TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CHEMICAL LABELING; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; INJECTION; INTRAMAMMARY LYMPH NODE; ISOTOPE LABELING; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RELIABILITY; SENTINEL LYMPH NODE BIOPSY; SKILL; SURGEON; TECHNIQUE; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CLINICAL COMPETENCE; COLORING AGENTS; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 61349177906     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.11.011     Document Type: Article

References (15)

1. Donegan W.L. Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 47 (1997) 28-51
2. Mansel R.E., Fallowfield L., Kissin M., et al. Randomised multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98 (2006) 599-609
3. Teal C., Slocum J., and Akin E. Evaluation of the benefit of using blue dye in addition to radioisotope for sentinel lymph node biopsy in patients with breast cancer. Breast J 11 6 (2005) 391-393
4. Syme D.B., Collins J.P., and Mann G.B. Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy. ANZ J Surg 75 9 (2005) 817-821
5. Chapgar A., Martin R.C., Chao C., et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 139 (2004) 614-620
6. 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification. Ann Surg Oncol 12 2 (2005) 167-172
7. Goyal A., Newcombe R.G., Chhabra A., Mansel R.E., and on behalf of the ALMANAC trialists group. Factors affecting failed localization and false-negative rates of sentinel node biopsy in breast cancer: results of the ALMANAC validation phase. Breast Cancer Res Treat 99 (2006) 203-208
8. Layeeque R., Kepple J., Henry-Tillman R.S., et al. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy. Ann Surg 239 (2004) 841-848
9. Julian T.B., Krag D., Brown A., et al. Preliminary technical results of NSABP B-32, a randomised phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node negative breast cancer patients. Breast Cancer Res Treat 88 (2004) 511-512
10. 99mTc-labeled sulfur colloid. Ann Surg Oncol 8 (2001) 821-827
11. Cody III H.S. The sentinel node concept: a critique of the critique. Breast 15 (2006) 571-574
12. Hinson J.L., McGrath P., Moore A., et al. The critical role of axillary ultrasound and aspiration biopsy in the management of breast cancer patients with clinically negative axilla. Ann Surg Oncol 15 1 (2008) 250-255
13. Wang L., Yu J.M., Wang Y.S., et al. Preoperative lymphoscintigraphy predicts the successful identification but is not necessary in sentinel lymph nodes biopsy in breast cancer. Ann Surg Oncol 14 (2007) 2215-2220
14. Goyal A., Newcombe R.G., Mansel R.E., and ALMANAC Trialists Group. Clinical relevance of internal mammary node drainage in sentinel node biopsy for breast cancer. J Clin Oncol 23 16S (2005) 519
15. Schwartz G.F., Giuliano A.E., Veronesi U., and Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19-22, 2001, Philadelphia, PA, USA. Breast 11 4 (2002) 362-373